Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 24, 2021

Primary Completion Date

April 30, 2028

Study Completion Date

December 30, 2028

Conditions
Solid TumorNon-Small Cell Lung CancerHead and Neck CancerColorectal Cancer
Interventions
DRUG

MCLA-129

MCLA-129 will be administered by intravenous infusion on the 28-day treatment cycle.

Trial Locations (78)

Unknown

RECRUITING

Affiliated Hospital of Hebei University, Baoding

RECRUITING

Beijing Cancer Hospital, Beijing

NOT_YET_RECRUITING

Beijing Friendship Hospital, Capital Medical University, Beijing

RECRUITING

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

RECRUITING

Peking University International Hospital, Beijing

RECRUITING

The Fifth Medical Center of PLA Ceneral Hospital, Beijing

RECRUITING

The First Affiliated Hospital of Bengbu Medical College, Bengbu

RECRUITING

Cangzhou Hospital of Integrated TCM-WM·Hebei, Cangzhou

RECRUITING

Ji Lin Cancer Hospital, Changchun

RECRUITING

Hunan Cancer Hospital, Changsha

NOT_YET_RECRUITING

Hunan Cancer Hospital, Changsha

RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

RECRUITING

Sichuan Cancer Hospital, Chengdu

RECRUITING

West China Hospital, Sichuan University, Chengdu

RECRUITING

Chifeng Municipal Hospital, Chifeng

RECRUITING

Army Medical Center of PLA, Chongqing

RECRUITING

Chongqing University Cancer Hospital, Chongqing

RECRUITING

China-Japan Union Hospitai Of Jilin University, Ch’ang-ch’un

NOT_YET_RECRUITING

The First Affiliated Hospital of Dalian Medical University, Dalian

RECRUITING

Fujian Cancer Hospital, Fuzhou

RECRUITING

Fuzhou Pulmonary Hospital of Fujian, Fuzhou

RECRUITING

The 900 Hospital of the Joint Service Support Force of the People's Liberation Army of China, Fuzhou

RECRUITING

First Affiliated Hospital Of Gannan Medical University, Ganzhou

RECRUITING

Guangdong Province Traditional Chinese Medical Hospital, Guangzhou

RECRUITING

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

RECRUITING

The Frist Affiliated Hospital of Guangzhou Medical College, Guangzhou

NOT_YET_RECRUITING

The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou

RECRUITING

Cancer Hospital of The University of Chinese Academy of Sciences, Hangzhou

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

NOT_YET_RECRUITING

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

RECRUITING

Hanzhong Central Hospital, Hanzhong

RECRUITING

Cancer Hospital affiliated to Harbin Medical University, Ha’erbin

NOT_YET_RECRUITING

Harbin Medical University cancer hospital, Ha’erbin

RECRUITING

The Second Hospital of Anhui Medical University, Hefei

RECRUITING

Inner Mongolia People's Hospital, Hohhot

RECRUITING

Jiangxi cancer hospital, Jiangxi

RECRUITING

The First Hospital of Jilin University, Jilin

RECRUITING

Shandong Cancer Hospital & institute, Jinan

RECRUITING

Yunnan Cancer Hospital, Kunming

RECRUITING

The First Hospital of Lanzhou University, Lanzhou

RECRUITING

General Hospital of Eastern Theater Command, Nanjing

RECRUITING

Jiangsu Cancer Hospital, Nanjing

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

RECRUITING

Nantong Tumor Hospital, Nantong

RECRUITING

Qingdao Central Hospital, Qingdao

RECRUITING

The Affiliated Hospital of Qingdao University, Qingdao

RECRUITING

First Hospital of Qinhuangdao, Qinhuangdao

RECRUITING

ShangHai Chest Hospital, Shanghai

RECRUITING

Liaoning Cancer Hospital & Institute, Shenyang

NOT_YET_RECRUITING

Liaoning Cancer Hospital & Institute, Shenyang

RECRUITING

The First Hospital of China Medical University, Shenyang

RECRUITING

Cancer Hospital of Chinese Academy of Medical Sciences Shenzhen Hospital, Shenzhen

RECRUITING

Shenzhen People's Hospital, Shenzhen

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

RECRUITING

Shanxi Provincial Cancer Hospital, Taiyuan

RECRUITING

Taizhou Hospital of Zhejiang Province, Taizhou

RECRUITING

General Hospital of Tianjin Medical University, Tianjin

RECRUITING

Tianjin Medical University Cancer Institute & Hospital, Tianjin

NOT_YET_RECRUITING

Tianjin Medical University Cancer Institute & Hospital, Tianjin

RECRUITING

Tonghua Central Hospital, Tonghua

RECRUITING

Weifang People's Hospital, Weifang

RECRUITING

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

NOT_YET_RECRUITING

Hubei Cancer Hospital, Wuhan

RECRUITING

Renmin Hospital of Wuhan University/Hubei General Hospital, Wuhan

RECRUITING

Union Hospital, Tongji Medical College Huazhong University of Science and Technolog, Wuhan

NOT_YET_RECRUITING

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

RECRUITING

Zhongnan Hospital Affiliated to Wuhan University, Wuhan

RECRUITING

The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital), Wuhu

RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

RECRUITING

The First Affiliated Hospital Of Xiamen University, Xiamen

RECRUITING

Xuzhou Central Hospital, Xuzhou

RECRUITING

Yantai Yuhuangding Hospital, Yantai

RECRUITING

The No. 2 People's Hospital of Yibin Sichuan, Yibin

RECRUITING

Hospital of Ningxia Medical University, Yinchuan

RECRUITING

He Nan Cancer Hospital, Zhengzhou

RECRUITING

Henan Provincial People's Hospital, Zhengzhou

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

NOT_YET_RECRUITING

Henan Provincial People's Hospital, Zhenzhou

All Listed Sponsors
lead

Betta Pharmaceuticals Co., Ltd.

INDUSTRY

NCT04930432 - Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors | Biotech Hunter | Biotech Hunter